COVID-19 in patients with glomerular disease.
Current opinion in nephrology and hypertension（2021）
Abstract
Patients with glomerular disease represent an at-risk group for severe COVID-19 disease and vaccination is key to reducing this risk. As immunosuppressed patients demonstrate an attenuated response to vaccination, the efficacy of a third primary dose followed by a subsequent booster is being investigated.
MoreTranslated text
Key words
COVID-19, glomerular disease, SARS-CoV-2, vaccination
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined